Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Uri Yablonka Insider Profile
4 Followers
Uri Yablonka, EVP & Chief Business Officer, Director at Brainstorm Cell Therapeutics, holds 68.46K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).
Uri Yablonka has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP & Chief Business Officer, Director
Roles that Uri Yablonka holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 23, 2017 - Aug 23, 2018
Return:0.00%
The most profitable trade made by Uri Yablonka
Uri Yablonka's Trading History
List of latest transactions for each holding click on a transaction to see Uri Yablonka's performance on stock
You May Also Like
Uri Yablonka insider profile FAQ
What is the percentage of profitable transactions made by Uri Yablonka?
The percentage of profitable transactions made by Uri Yablonka is ―.
What is the average return per transaction made by Uri Yablonka?
The average return per transaction made by Uri Yablonka is ―.
What stocks does Uri Yablonka hold?
Uri Yablonka holds: BCLI stocks.
What was Uri Yablonka’s latest transaction?
Uri Yablonka latest transaction was an Uninformative Buy of ―.
What was Uri Yablonka's most profitable transaction?
Uri Yablonka’s most profitable transaction was an Informative Buy of BCLI stock on August 23, 2017. The return on the trade was 0.00%.
What is Uri Yablonka's role in Brainstorm Cell Therapeutics?
Uri Yablonka's role in Brainstorm Cell Therapeutics is EVP & Chief Business Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.